Division of Zimmer Biomet Holdings Inc.
Latest From Zimmer Spine
Benvenue cleared for vertebral augmentation alternative. ReCor recommits to renal denervation. Spine surgery firm plans IPO. More news.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced September through October 2013.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced August-October 2013.
Device tax repeal momentum. Johnson & Johnson/DePuy has settled a lawsuit from a California plaintiff related to injuries from the ASR hip implant. Rep. Marsha Blackburn is working on legislation to clarify FDA’s authority over mobile health apps. Zimmer will market Frontier’s Lateral Locking Cage. More news.
- Implantable Devices
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- Sulzer Spine-Tech Inc.
- Centerpulse Spine-Tech
- Zimmer Spinetech
- North America
- Parent & Subsidiaries
- Zimmer Biomet Holdings Inc.
- Senior Management
- Terry Schlotterback, Pres.
- Contact Info
Phone: (612) 832-5600
7375 Bush Lake Rd.
Minneapolis, MN 55439
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.